Gene promoter methylation patterns throughout the process of cervical carcinogenesis

Cellular Oncology

Volumn 32, Issue 1-2, 2010, Pages 131-143

  Yang, Nan ^a,b   Nijhuis, Esther R ^a   Volders, Haukeline H ^a   Eijsink, Jasper J H ^a   Lendvai, Ágnes ^a   Zhang, Bo ^b   Hollema, Harry ^a   Schuuring, Ed ^a   Wisman, G Bea A ^a   Van Der Zee, Ate G J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

CADM1; CCNA1; Cervical (intraepithelial) neoplasia; DAPK; Methylation

Indexed keywords

APC; DEATH ASSOCIATED PROTEIN KINASE; OSTEONECTIN; PROTEIN; PROTEIN CADM 1; PROTEIN CCNA 1; PROTEIN TFP 12; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ADULT; ARTICLE; CANCER INVASION; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA ISOLATION; FEMALE; GENE FREQUENCY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; METHYLATION; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; VIRUS DETECTION; WART VIRUS;

CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA METHYLATION; FEMALE; HUMANS; MIDDLE AGED; NEOPLASTIC PROCESSES; PROMOTER REGIONS, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 77749273438     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: 10.3233/CLO-2009-0510     Document Type: Article

References (41)

1. N. Ahuja and J.P. Issa, Aging, methylation and cancer, Histol. Histopathol. 15 (2000), 835-842.
2. M.F. Baay, W.G. Quint, J. Koudstaal, H. Hollema, J.M. Duk, M.P. Burger, E. Stolz and P. Herbrink, Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas, J. Clin. Microbiol. 34 (1996), 745-747.
3. S.B. Baylin, M. Esteller, M.R. Rountree, K.E. Bachman, K. Schuebel and J.G. Herman, Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer, Hum. Mol. Genet. 10 (2001), 687-692.
4. W.A. Burgers, L. Blanchon, S. Pradhan, Y. de Launoit, T. Kouzarides and F. Fuks, Viral oncoproteins target the DNA methyltransferases, Oncogene 26 (2007), 1650-1655.
5. J. de Wilde, A.J. De-Castro, P.J. Snijders, C.J. Meijer, F. Rosl and R.D. Steenbergen, Alterations in AP-1 and AP-1 regulatory genes during HPV-induced carcinogenesis, Cell Oncol. 30 (2008), 77-87.
6. S.M. Dong, H.S. Kim, S.H. Rha and D. Sidransky, Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix, Clin. Cancer Res. 7 (2001), 1982-1986.
7. C.A. Eads, K.D. Danenberg, K. Kawakami, L.B. Saltz, C. Blake, D. Shibata, P.V. Danenberg and P.W. Laird, Methy-Light: a high-throughput assay to measure DNA methylation, Nucleic Acids Res. 28 (2000), E32.
8. Q. Feng, A. Balasubramanian, S.E. Hawes, P. Toure, P.S. Sow, A. Dem, B. Dembele, C.W. Critchlow, L. Xi, H. Lu, M.W. McIntosh, A.M. Young and N.B. Kiviat, Detection of hyperme-thylated genes in women with and without cervical neoplasia, J. Natl. Cancer Inst. 97 (2005), 273-282.
9. S.E. Goelz, S.R. Hamilton and B. Vogelstein, Purification of DNA from formaldehyde fixed and paraffin embedded human tissue, Biochem. Biophys. Res. Commun. 130 (1985), 118-126.
10. K.S. Gustafson, E.E. Furth, D.F. Heitjan, Z.B. Fansler and D.P. Clark, DNA methylation profiling of cervical squamous in-traepithelial lesions using liquid-based cytology specimens: an approach that utilizes receiver-operating characteristic analysis, Cancer 102 (2004), 259-268.
11. F.E. Henken, S.M. Wilting, R.M. Overmeer, J.G. van Ri-etschoten, A.O. Nygren, A. Errami, J.P. Schouten, C.J. Meijer, P.J. Snijders and R.D. Steenbergen, Sequential gene promoter methylation during HPV-induced cervical carcinogenesis, Br. J. Cancer 97 (2007), 1457-1464.
12. R.P. Insinga, K.L. Liaw, L.G. Johnson and M.M. Madeleine, A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar pre-cancers and cancers in the United States, Cancer Epidemiol. Biomarkers Prev. 17 (2008), 1611-1622.
13. T. Ivanova, A. Petrenko, T. Gritsko, S. Vinokourova, E. Eshilev, V. Kobzeva, F. Kisseljov and N. Kisseljova, Methylation and silencing of the retinoic acid receptor-beta 2 gene in cervical cancer, BMC Cancer 2 (2002), 4.
14. P.A. Jones and M.L. Gonzalgo, Altered DNA methylation and genome instability: a new pathway to cancer?, Proc. Natl. Acad. Sci. USA 94 (1997), 2103-2105.
15. S.L. Kahn, B.M. Ronnett, P.E. Gravitt and K.S. Gustafson, Quantitative methylation-specific PCR for the detection of aberrant DNA methylation in liquid-based Pap tests, Cancer 114 (2008), 57-64.
16. F. Kamangar, G.M. Dores and W.F. Anderson, Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world, J. Clin. Oncol. 24 (2006), 2137-2150.
17. S. Kang, J.W. Kim, G.H. Kang, S. Lee, N.H. Park, Y.S. Song, S.Y. Park, S.B. Kang and H.P. Lee, Comparison of DNA hyper-methylation patterns in different types of uterine cancer: Cervical squamous cell carcinoma, cervical adenocarcinoma and endometrial adenocarcinoma, Int. J. Cancer 118 (2006), 2168-2171.
18. N. Kitkumthorn, P. Yanatassaneejit, S. Kiatpongsan, C. Phokaew, P. Trivijitsilp, W. Termrungruanglert, D. Tre-sukosol, S. Triratanachat, S. Niruthisard and A. Mutiran-gura, Cyclin A1 promoter hypermethylation in human papillomavirus-associated cervical cancer, BMC Cancer 6 (2006), 55.
19. H.C. Lai, Y.W. Lin, C.C. Chang, H.C. Wang, T.W. Chu, M.H. Yu and T.Y. Chu, Hypermethylation of two consecutive tumor suppressor genes, BLU and RASSF1A, located at 3p21.3 in cervical neoplasias, Gynecol. Oncol. 104 (2007), 629-635.
20. H.L. Lung, A.K. Cheung, D. Xie, Y. Cheng, F.M. Kwong, Y. Murakami, X.Y. Guan, J.S. Sham, D. Chua, A.I. Protopopov, E.R. Zabarovsky, S.W. Tsao, E.J. Stanbridge and M.L. Lung, TSLC1 is a tumor suppressor gene associated with metastasis in nasopharyngeal carcinoma, Cancer Res. 66 (2006), 9385-9392. (Pubitemid 44623634)
21. M.R. McCredie, K.J. Sharples, C. Paul, J. Baranyai, G. Medley, R.W. Jones and D.C. Skegg, Natural history of cervical neopla-sia and risk of invasive cancer in women with cervical intraep-ithelial neoplasia 3: a retrospective cohort study, Lancet Oncol. 9 (2008), 425-434.
22. M.F. Mitchell, G. Tortolero-Luna, T. Wright, A. Sarkar, R. Richards-Kortum, W.K. Hong and D. Schottenfeld, Cervical human papillomavirus infection and intraepithelial neoplasia: a review, J. Natl. Cancer Inst. Monogr. 21 (1996), 17-25.
23. H.M. Müller, A. Widschwendter, H. Fiegl, G. Goebel, A. Wiedemair, E. Muller-Holzner, C. Marth and M. Wid-schwendter, A DNA methylation pattern similar to normal tissue is associated with better prognosis in human cervical cancer, Cancer Lett. 209 (2004), 231-236.
24. G. Narayan, H. Arias-Pulido, S. Koul, H. Vargas, F.F. Zhang, J. Villella, A. Schneider, M.B. Terry, M. Mansukhani and V.V. Murty, Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: Its relationship to clinical outcome, Mol. Cancer 2 (2003), 24.
25. D.M. Parkin, P. Pisani and J. Ferlay, Estimates of the worldwide incidence of 25 major cancers in 1990, Int. J. Cancer 80 (1999), 827-841. (Pubitemid 29108856)
26. J. Peto, C. Gilham, O. Fletcher and F.E. Matthews, The cervical cancer epidemic that screening has prevented in the UK, Lancet 364 (2004), 249-256.
27. N. Reesink-Peters, G.B.A. Wisman, C. Jerónimo, C.Y. Toku-maru, Y. Cohen, S.M. Dong, H.G. Klip, H.J. Buikema, A.J. Su-urmeijer, H. Hollema, H.M. Boezen, D. Sidransky and A.G.J. van der Zee, Detecting cervical cancer by quantitative promoter hypermethylation assay on cervical scrapings: a feasibility study, Mol. Cancer Res. 2 (2004), 289-295.
28. M. Sawada, Y. Kanai, E. Arai, S. Ushijima, H. Ojima and S. Hirohashi, Increased expression of DNA methyltransferase 1 (DNMT1) protein in uterine cervix squamous cell carcinoma and its precursor lesion, Cancer Lett. 251 (2007), 211-219.
29. M. Schiffman, M.J. Khan, D. Solomon, R. Herrero, S. Wa-cholder, A. Hildesheim, A.C. Rodriguez, M.C. Bratti, C.M. Wheeler and R.D. Burk, A study of the impact of adding HPV types to cervical cancer screening and triage tests, J. Natl. Cancer Inst. 97 (2005), 147-150.
30. N. Shivapurkar, M.E. Sherman, V. Stastny, C. Echebiri, J.S. Rader, R. Nayar, T.A. Bonfiglio, A.F. Gazdar and S.S. Wang, Evaluation of candidate methylation markers to detect cervical neoplasia, Gynecol. Oncol. 107 (2007), 549-553.
31. N. Shivapurkar, S. Toyooka, K.O. Toyooka, J. Reddy, K. Miya-jima, M. Suzuki, H. Shigematsu, T. Takahashi, G. Parikh, H.I. Pass, P.M. Chaudhary and A.F. Gazdar, Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types, Int. J. Cancer 109 (2004), 786-792.
32. P.J. Snijders, R.D. Steenbergen, D.A. Heideman and C.J. Mei-jer, HPV-mediated cervical carcinogenesis: concepts and clinical implications, J. Pathol. 208 (2006), 152-164.
33. P. Sova, Q. Feng, G. Geiss, T. Wood, R. Strauss, V. Rudolf, A. Lieber and N. Kiviat, Discovery of novel methylation bio-markers in cervical carcinoma by global demethylation and microarray analysis, Cancer Epidemiol. Biomarkers Prev. 15 (2006), 114-123.
34. R.D. Steenbergen, D. Kramer, B.J. Braakhuis, P.L. Stern, R.H. Verheijen, C.J. Meijer and P.J. Snijders, TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia, J. Natl. Cancer Inst. 96 (2004), 294-305.
35. J.J. van Dongen, A.W. Langerak, M. Bruggemann, P.A. Evans, M. Hummel, F.L. Lavender, E. Delabesse, F. Davi, E. Schuur-ing, R. Garcia-Sanz, J.H. Van Krieken, J. Droese, D. Gonzalez, C. Bastard, H.E. White, M. Spaargaren, M. Gonzalez, A. Par-reira, J.L. Smith, G.J. Morgan, M. Kneba and E.A. Macintyre, Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936, Leukemia 17 (2003), 2257-2317.
36. A.K. Virmani, C. Muller, A. Rathi, S. Zoechbauer-Mueller, M. Mathis and A.F. Gazdar, Aberrant methylation during cervical carcinogenesis, Clin. Cancer Res. 7 (2001), 584-589.
37. J. Visser, D. van Baarle, B.N. Hoogeboom, N. Reesink, H. Klip, E. Schuuring, E. Nijhuis, M. Pawlita, L. Bungener, J. de Vries-Idema, H. Nijman, F. Miedema, T. Daemen and A.G.J. van der Zee, Enhancement of human papilloma virus type 16 E7 specific T cell responses by local invasive procedures in patients with (pre)malignant cervical neoplasia, Int. J. Cancer 118 (2006), 2529-2537.
38. N. Wentzensen, M.E. Sherman, M. Schiffman and S.S. Wang, Utility of methylation markers in cervical cancer early detection: Appraisal of the state-of-the-science, Gynecol. Oncol. 112 (2008), 293-299.
39. A. Widschwendter, C. Gattringer, L. Ivarsson, H. Fiegl, A. Schneitter, A. Ramoni, H.M. Muller, A. Wiedemair, S. Jer-abek, E. Muller-Holzner, G. Goebel, C. Marth and M. Wid-schwendter, Analysis of aberrant DNA methylation and human papillomavirus DNA in cervicovaginal specimens to detect invasive cervical cancer and its precursors, Clin. Cancer Res. 10 (2004), 3396-3400.
40. G.B.A. Wisman, H. Hollema, S. de Jong, J. ter Schegget, S.P. Tjong-A-Hung, M.H.J. Ruiters, M. Krans, E.G.E. de Vries and A.G.J. van der Zee, Telomerase activity as a biomarker for (pre)neoplastic cervical disease in scrapings and frozen sections from patients with abnormal cervical smear, J. Clin. Oncol. 16 (1998), 2238-2245.
41. G.B.A. Wisman, E.R. Nijhuis, M.O. Hoque, N. Reesink-Peters, A.J. Koning, H.H. Volders, H.J. Buikema, H.M. Boezen, H. Hollema, E. Schuuring, D. Sidransky and A.G.J. van der Zee, Assessment of gene promoter hypermethylation for detection of cervical neoplasia, Int. J. Cancer 119 (2006), 1908-1914.